Growth Metrics

Omeros (OMER) Operating Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.96%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -50.81%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.47%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 55.96%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 21.28%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.28%
Dec 31, 2025 10.18%
Sep 30, 2025 19.59%
Jun 30, 2025 4.75%
Mar 31, 2025 0.07%
Dec 31, 2024 8.04%
Sep 30, 2024 3.85%
Jun 30, 2024 -9.06%
Mar 31, 2024 4.83%
Dec 31, 2023 -5.55%
Sep 30, 2023 -23.72%
Jun 30, 2023 -13.90%
Mar 31, 2023 -14.68%
Dec 31, 2022 -19.19%
Sep 30, 2022 -65.99%
Jun 30, 2022 -58.86%
Mar 31, 2022 -22.13%
Dec 31, 2021 -32.41%
Sep 30, 2021 -3.97%
Jun 30, 2021 -14.21%
Mar 31, 2021 -17.82%
Dec 31, 2020 -33.79%
Sep 30, 2020 -70.72%
Jun 30, 2020 -32.35%
Mar 31, 2020 -23.00%
Dec 31, 2019 -25.97%
Sep 30, 2019 2.66%
Jun 30, 2019 5.11%
Mar 31, 2019 0.37%
Dec 31, 2018 -0.80%
Sep 30, 2018 -22.46%
Jun 30, 2018 -24.24%
Mar 31, 2018 -15.59%
Dec 31, 2017 10.92%
Sep 30, 2017 33.19%
Jun 30, 2017 11.49%
Mar 31, 2017 6.73%
Dec 31, 2016 5.17%
Sep 30, 2016 3.59%
Jun 30, 2016 6.00%
Mar 31, 2016 -24.75%
Dec 31, 2015 -33.79%
Sep 30, 2015 -13.98%
Jun 30, 2015 -24.65%
Mar 31, 2015 -30.48%
Dec 31, 2014 -26.59%
Sep 30, 2014 -40.60%
Jun 30, 2014 -51.52%
Mar 31, 2014 -34.47%
Dec 31, 2013 -17.56%
Sep 30, 2013 -21.50%
Jun 30, 2013 -19.90%